World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02188862
Date of registration: 10/07/2014
Prospective Registration: No
Primary sponsor: University of Oxford
Public title: Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region
Scientific title: Genome-wide Association Study of Susceptibility to Rheumatic Heart Disease in Fiji and New Caledonia
Date of first enrolment: September 2012
Target sample size: 2372
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02188862
Study type:  Observational
Study design:  Observational Model: Case Control, Time Perspective: Retrospective  
Phase:  N/A
Countries of recruitment
Fiji New Caledonia United Kingdom
Contacts
Name:     Adrian VS Hill, DPhil DM
Address: 
Telephone:
Email:
Affiliation:  University of Oxford
Name:     Mariana Mirabel, MD
Address: 
Telephone:
Email:
Affiliation:  Institut National de la Santé Et de la Recherche Médicale, France
Name:     Tom Parks, MRCP DTM&H
Address: 
Telephone:
Email:
Affiliation:  University of Oxford
Name:     Andrew C Steer, FRACP PhD
Address: 
Telephone:
Email:
Affiliation:  University of Melbourne
Key inclusion & exclusion criteria

1. Cases

1. Inclusion Criteria:

- Diagnosis of rheumatic heart disease based on one of:

- World Heart Federation definite echocardiographic criteria

- World Heart Federation borderline echocardiographic criteria and
history of acute rheumatic fever

- Mitral stenosis with valve area less than 2.0 cm2

- Previous surgery for rheumatic heart disease

2. Exclusion Criteria:

- Age less than five years

- Inability to give consent

2. New Controls

1. Inclusion criteria:

- Healthy individual living in a community where cases were identified

2. Exclusion Criteria:

- Past medical history or systems suggestive of rheumatic heart disease,
acute rheumatic fever or other valvular heart disease

- Age less than five years

- Inability to give consent



Age minimum: 5 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Mitral Stenosis
Rheumatic Heart Disease
Intervention(s)
Primary Outcome(s)
Rheumatic heart disease diagnosis [Time Frame: At enrolment]
Secondary Outcome(s)
Mitral stenosis diagnosis [Time Frame: At enrolment]
Secondary ID(s)
PACIFICRHDGEN
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Fiji Islands Ministry of Health
Centre Hospitalier Territorial de Nouvelle Calédonie
Fiji National University
Institut Necker Enfants Malades
Institut National de la Santé Et de la Recherche Médicale, France
University of Melbourne
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history